AR223989A1 - Un procedimiento para producir alfa,alfa,alfa-trifluoro(aminofenil)etanoles - Google Patents

Un procedimiento para producir alfa,alfa,alfa-trifluoro(aminofenil)etanoles

Info

Publication number
AR223989A1
AR223989A1 AR278751A AR27875179A AR223989A1 AR 223989 A1 AR223989 A1 AR 223989A1 AR 278751 A AR278751 A AR 278751A AR 27875179 A AR27875179 A AR 27875179A AR 223989 A1 AR223989 A1 AR 223989A1
Authority
AR
Argentina
Prior art keywords
alpha
trifluorine
ethanols
aminophenyl
procedure
Prior art date
Application number
AR278751A
Other languages
English (en)
Spanish (es)
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Application granted granted Critical
Publication of AR223989A1 publication Critical patent/AR223989A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AR278751A 1978-11-03 1979-11-02 Un procedimiento para producir alfa,alfa,alfa-trifluoro(aminofenil)etanoles AR223989A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
AR223989A1 true AR223989A1 (es) 1981-10-15

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
AR278751A AR223989A1 (es) 1978-11-03 1979-11-02 Un procedimiento para producir alfa,alfa,alfa-trifluoro(aminofenil)etanoles
AR278752A AR223990A1 (es) 1978-11-03 1979-11-12 Un procedimiento para producir una novedosa composicion farmaceutica conteniendo ariltrifluoroetanol,con actividad analgesica,antipiretica y/o antiinflamatoria

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR278752A AR223990A1 (es) 1978-11-03 1979-11-12 Un procedimiento para producir una novedosa composicion farmaceutica conteniendo ariltrifluoroetanol,con actividad analgesica,antipiretica y/o antiinflamatoria

Country Status (27)

Country Link
US (2) US4285943A (da)
JP (2) JPS5566510A (da)
AR (2) AR223989A1 (da)
AT (1) AT368483B (da)
AU (1) AU527630B2 (da)
BE (2) BE879786A (da)
CA (2) CA1142087A (da)
CH (2) CH647225A5 (da)
DD (2) DD147048A5 (da)
DE (2) DE2944293A1 (da)
DK (2) DK461579A (da)
EG (1) EG14114A (da)
ES (1) ES485656A0 (da)
FI (2) FI793444A (da)
FR (1) FR2440353A1 (da)
GB (2) GB2038802B (da)
GR (2) GR68015B (da)
IL (2) IL58620A (da)
IT (2) IT7950715A0 (da)
MA (2) MA18629A1 (da)
NL (2) NL7908101A (da)
NZ (2) NZ192021A (da)
OA (2) OA06372A (da)
PT (2) PT70408A (da)
SE (2) SE7909105L (da)
SU (1) SU925247A3 (da)
ZA (2) ZA795870B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EP2396081B1 (en) 2009-02-16 2017-04-05 Nogra Pharma Limited Alkylamido compounds and uses thereof
MX364220B (es) 2012-02-09 2019-04-16 Nogra Pharma Ltd Metodos de tratamientos de fibrosis.
IN2014DN08157A (da) 2012-04-18 2015-05-01 Nogra Pharma Ltd
WO2020161362A1 (en) 2019-02-08 2020-08-13 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
GR66480B (da) * 1977-10-07 1981-03-24 Science Union & Cie

Also Published As

Publication number Publication date
CA1139763A (fr) 1983-01-18
JPS5566510A (en) 1980-05-20
BE879787A (fr) 1980-04-30
PT70407A (en) 1979-12-01
AU527630B2 (en) 1983-03-17
DE2944294A1 (de) 1980-05-08
MA18629A1 (fr) 1980-07-01
NZ192021A (en) 1982-09-07
EG14114A (en) 1983-03-31
AU5241679A (en) 1980-05-08
ZA795871B (en) 1980-10-29
OA06372A (fr) 1981-08-31
NL7908099A (nl) 1980-05-07
OA06373A (fr) 1981-08-31
JPS5566548A (en) 1980-05-20
SE7909105L (sv) 1980-05-04
DD151445A5 (de) 1981-10-21
GB2038802B (en) 1982-12-08
DE2944293A1 (de) 1980-05-08
DD147048A5 (de) 1981-03-18
IL58620A (en) 1982-12-31
GB2034587A (en) 1980-06-11
IL58620A0 (en) 1980-02-29
DK461579A (da) 1980-05-04
MA18628A1 (fr) 1980-07-01
GB2038802A (en) 1980-07-30
ZA795870B (en) 1980-10-29
BE879786A (fr) 1980-04-30
ES8101538A1 (es) 1980-12-16
US4285943A (en) 1981-08-25
FI793444A (fi) 1980-05-04
FI793445A (fi) 1980-05-04
CH647225A5 (fr) 1985-01-15
AT368483B (de) 1982-10-11
ES485656A0 (es) 1980-12-16
NL7908101A (nl) 1980-05-07
FR2440353A1 (fr) 1980-05-30
IT7950715A0 (it) 1979-10-31
AR223990A1 (es) 1981-10-15
GR68015B (da) 1981-10-27
IL58621A0 (en) 1980-02-29
SE7909106L (sv) 1980-05-04
PT70408A (fr) 1979-12-01
NZ192020A (en) 1982-12-21
DK461679A (da) 1980-05-04
GB2034587B (en) 1983-02-09
US4404215A (en) 1983-09-13
SU925247A3 (ru) 1982-04-30
IT7950714A0 (it) 1979-10-31
CA1142087A (fr) 1983-03-01
ATA701679A (de) 1982-02-15
CH641043A5 (fr) 1984-02-15
GR69726B (da) 1982-07-09

Similar Documents

Publication Publication Date Title
MX5132E (es) Procedimiento para preparar un alcano de bispiridinio
ES497084A0 (es) Un procedimiento para preparar nuevos compuestos de tiazol.
ES508446A0 (es) Procedimiento para producir un polipeptido.
AR221717A1 (es) Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona
AR224493A1 (es) Un procedimiento para la produccion de n-fosfonometil glicina
ES490503A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
AR222645A1 (es) Procedimiento para preparar un 3-oxo-4alfa,5alfa-epoxi-10,13-dimetil-esteroide-2alfa-carbonitrilo
ES487847A0 (es) Un procedimiento para preparar nuevas fenetanolaminas
ES486425A0 (es) Un procedimiento para preparar nuevas 4-arilpiperinas.
AR220892A1 (es) Procedimiento para preparar(piridazinil-3)-5-ditiol-1,2 tiona-3
AR224494A1 (es) Un procedimiento para preparar cefalexina de accion prolongada
MX4323E (es) Procedimiento para preparar un aminoglicosido de 2-deoxiestreptamina
AR223978A1 (es) Un procedimiento para preparar un mercaptano
ES491221A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
AR223989A1 (es) Un procedimiento para producir alfa,alfa,alfa-trifluoro(aminofenil)etanoles
ES490101A0 (es) Un procedimiento para obtener 2,6-diaminonebularinas
MX5790E (es) Procedimiento para preparar 1,2,3-tiadiazol-5-il ureas
AR224149A1 (es) Un procedimiento para producir piran-4-onas
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
AR223166A1 (es) Procedimiento para la obtencion de un catalizador
AR226031A1 (es) Procedimiento para la obtencion de un catalizador
MX4499E (es) Procedimiento para preparar 2-oxi-5-isopropiliden-7-hidroxi-9-substituido-2,6-metano-3,4,5,6-tetrahidro-2h-1-benzoxocinas
ES493760A0 (es) Un procedimiento para preparar benzoxazepinas.
ES488851A0 (es) Un procedimiento para purificar caprolactama.
MX4697E (es) Procedimiento para preparar 1,2,3-tiadiazol-5-il-ureas